Document is current
Any future updates will be listed below
-
Authors
Cooney, Erin E. https://orcid.org/0000-0001-9563-1822
Stevenson, Meg
Aguayo-Romero, Rodrigo A.
Valera, Genesis
Poteat, Tonia C.
Mayer, Kenneth H.
Beyrer, Chris
Althoff, Keri N.
Radix, Asa E.
Wawrzyniak, Andrew J.
Cannon, Christopher M.
Schneider, Jason S.
Brown, Carolyn A.
Vannappagari, Vani
Ragone, Leigh
de Ruiter, Annemiek
Reisner, Sari L.
Wirtz, Andrea L.
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UG3/UH3AI133669)
NIMH (F31MH124582)
ViiV Healthcare
- License Information
-
More Information
Article History
Accepted: 19 November 2024
First Online: 5 December 2024
Declarations
:
: EEC, ALW, and TCP received funding support from ViiV healthcare to support this analysis through a grant to their institutions. VV, AdR, and LR are employed by ViiV Healthcare and receive stock from GSK. CAB was employed by ViiV Healthcare and received stock from GSK while this manuscript was in preparation. The remaining authors do not have declarations to disclose.
